RNAC icon

Cartesian Therapeutics
RNAC

Overview Fund Trends Analyst Outlook Journalist POV

36 hedge funds and large institutions have $32.4M invested in Cartesian Therapeutics in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 16 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10: →

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

56% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 16

73% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 11

Holders
36
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$53K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$285K
2
+$44.7K
3
+$23K
4
Two Sigma Investments
Two Sigma Investments
New York
+$20K
5
Deutsche Bank
Deutsche Bank
Germany
+$15.9K

Top Sellers

1
-$977K
2
-$824K
3
-$758K
4
Northern Trust
Northern Trust
Illinois
-$524K
5
Millennium Management
Millennium Management
New York
-$253K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$21K
27
$20K
28
$19K
29
$17K
30
$13K
31
$7K
32
$6.65K
33
$5K
34
$2K
35
$1K
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
45
–
1
2